Osteopontin expression in human cyclosporine toxicity

Kidney International

Volumn 60, Issue 2, 2001, Pages 635-640

  Hudkins, Kelly L ^a   Le, Quoc C ^a   Segerer, Stephan ^a   Johnson, Richard J ^a   Davis, Connie L ^a   Giachelli, Cecilia M ^a   Alpers, Charles E ^a  

^a University of Washington   (United States)

Author keywords

Immunosuppression; Macrophages; Nephrotoxicity; Renal biopsy; Renal injury; Transplantation

Indexed keywords

CD68 ANTIGEN; CYCLOSPORIN; MESSENGER RNA; OSTEOPONTIN;

CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MACROPHAGE MIGRATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS;

EID: 0034921565     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.060002635.x     Document Type: Article

References (36)

1. Improved graft survival after renal transplantation in the United States, 1988 to 1996
2. The long-term course of cyclosporine-associated chronic nephropathy
3. Cyclosporine-associated chronic nephropathy
4. Osteopontin: A protein with diverse functions
5. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro
6. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival
7. The nature and significance of osteopontin
8. Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces
9. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR)
10. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques
11. Macrophages express osteopontin during repair of myocardial necrosis
12. Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: A potential requirement for macrophage adhesion and phagocytosis
13. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta
14. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques
15. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo
16. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo
17. Osteopontin expression in fetal and mature human kidney
18. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli
19. Ultrastructural localization of osteopontin in the kidney: Induction by lipopolysaccharide
20. Osteopontin in chronic puromycin aminonucleoside nephrosis
21. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis
22. Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin)
23. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin
24. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat
25. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis
26. Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion
27. Osteopontin expression in human crescentic glomerulonephritis
28. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone
29. PG-M1: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule
30. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and Rflp analysis of human osteopontin (Opn)
31. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria
32. Lack of in vivo function of osteopontin in experimental anti-GBM nephritis
33. Upregulation of osteopontin expression by ischemia in rat kidney
34. Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene
35. Insights into chronic cyclosporine nephrotoxicity
36. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity